CDK5 and neoplasm: MiR-27a was identified as a tumor suppressor to be downregulated in MM [46] and leukemia [47] cells and targeted the oncogenes CDK5 and P-glycoprotein, respectively, which were highly expressed in tumor cells culminating in the same outcome as above.